HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity

References

• Ait-Khaled M, McLaughlin JE, Johnson MA, Emery VC (1995). Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient. Aids 9: 675–683.
   PubMed Web of Science ®Google Scholar
• Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T (1990). A nu-clear factor for IL-6 expression (NF-1L6) is a member of a C/EBP family. EMBO J 9: 1897–1906.
   PubMed Web of Science ®Google Scholar
• Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Rapp BA, Wheeler DL (2000). GenBank. Nucleic Acids Res 28: 15–18.
   PubMed Web of Science ®Google Scholar
• Bronstein I, Voyta JC, Murphy 0J, Bresnick L, Kricka LJ (1992). Improved chemiluminescent Western blotting procedure. Biotechniques 12: 748–753.
   Google Scholar
• Burnette WN (1981). "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodi-nated protein A. Anal Biochem 112: 195–203.
   PubMed Web of Science ®Google Scholar
• Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J (1996). The beta-chemokine re-ceptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85: 1135–1148.
   PubMed Web of Science ®Google Scholar
• Corboy JR, Buzy JM, Zink MC, Clements JE (1992). Ex-pression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 258: 1804–1808.
   PubMed Web of Science ®Google Scholar
• Corboy JR, Garl PJ (1997). HIV-1 LTR DNA sequence vari-ation in brain-derived isolates. I NeuroVirol 3: 331–341.
   PubMed Web of Science ®Google Scholar
• Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI (1994). Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobil-ity assays. I Virol 68: 6672–6683.
   Google Scholar
• Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996). Identification of a major co-receptor for primary isolates of HIV-1 [see comments]. Nature 381: 661–666.
   PubMed Web of Science ®Google Scholar
• Dignam JD, Lebovitz RM, Roeder RG (1983). Accurate tran-scription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475–1489.
   PubMed Web of Science ®Google Scholar
• Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW (1996). A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85: 1149–1158.
   PubMed Web of Science ®Google Scholar
• Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996). HIV-1 entry into CD4+ cells is me-diated by the chemokine receptor CC- CKR-5 [see com-ments]. Nature 381: 667–673.
   PubMed Web of Science ®Google Scholar
• Estable MC, Bell B, Merzouki A, Mont aner JS, O'Shaughnessy MV, Sadowski IJ (1996). Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of in-fection display a wide range of sequence polymorphism and transcription activity. I Virol 70: 4053–4062.
   PubMed Web of Science ®Google Scholar
• Feng Y, Broder CC, Kennedy PE, Berger EA (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor [see comments]. Science 272: 872–877.
   PubMed Web of Science ®Google Scholar
• Gallo P, Frei K, Rordorf C, Lazdins J, Tavolato B, Fontana A (1989). Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol 23: 109–116.
   PubMed Web of Science ®Google Scholar
• Geleziunas R, Schipper HM, Wainberg MA (1992). Patho-genesis and therapy of HIV-1 infection of the central ner-vous system [editorial]. Aids 6: 1411–1126.
   PubMed Web of Science ®Google Scholar
• Gillespie PG, Hudspeth AJ (1991). Chemiluminescence de-tection of proteins from single cells. Proc Nati Acad Sci USA 88: 2563–2567.
   PubMedGoogle Scholar
• Henderson AJ, Calame KL (1997). CCAAT/enhancer bind-ing protein (C/EBP) sites are required for HIV-1 repli-cation in primary macrophages but not CD4(±) T cells. Proc Natl Acad Sci USA 94: 8714–8719.
   PubMed Web of Science ®Google Scholar
• Henderson AJ, Connor RI, Calame KL (1996). C/EBP ac-tivators are required for HIV-1 replication and provi-ral induction in monocytic cell lines. Immunity 5: 91–101.
   PubMed Web of Science ®Google Scholar
• Henderson AJ, Zou X, Calame KL (1995). C/EBP pro-teins activate transcription from the human immun-odeficiency virus type 1 long terminal repeat in macrophages/monocytes. I Virol 69: 5337–5347.
   PubMed Web of Science ®Google Scholar
• Ho DD, Bredesen DE, Vinters HV, Daar ES (1989). The acquired immunodeficiency syndrome (AIDS) demen-tia complex [clinical conference]. Ann Intern Med 111: 400–410.
   PubMedGoogle Scholar
• Kim FM, Kolson DL, Balliet JW, Srinivasan A, Collman RG (1995). V3-independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate. I Virol 69: 1755–1761.
   PubMedGoogle Scholar
• Kirchhoff F, Greenough TC, Hamacher M, Sullivan JL, Desrosiers RC (1997). Activity of human immunodefi-ciency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression. Virology 232: 319–331.
   Google Scholar
• Korber BT, Kunstman KJ, Patterson BK, Furtado M, McEvilly MM, Levy R, Wolinsky SM (1994). Genetic differences between blood- and brain-derived viral se-quences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. I Virol 68: 7467–7481.
   PubMed Web of Science ®Google Scholar
• Lipton SA, Gendelman HE (1995). Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associ-ated with the acquired immunodeficiency syndrome [see comments]. N Engl J Med 332: 934–940.
   Google Scholar
• Liu Y, Tang XP, McArthur JC, Scott J, Gartner S(2000). Anal-ysis of human immunodeficiency virus type 1 gp160 se-quences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J NeuroVirol 6 Suppl 1: S70–S81.
   Google Scholar
• Lukashov VV, Kuiken CL, Goudsmit J (1995). Intrahost hu-man immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. I Virol 69: 6911–6916.
   PubMed Web of Science ®Google Scholar
• Maxam AM, Gilbert W (1980). Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol 65: 499–560.
   PubMedGoogle Scholar
• McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B (2000). Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. Virology 274: 262–277.
   Google Scholar
• McArthur JC, Hoover DR, Bacellar H, Miller EN, Co-hen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP (1993). Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43: 2245–2252.
   Google Scholar
• Michael NL, D'Arcy L, Ehrenberg PK, Redfield RR (1994). Naturally occurring genotypes of the human immunode-ficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. Virol 68: 3163–3174.
   Google Scholar
• Pang S, Shle singer Y, Daar ES, Moudgil T, Ho DD, Chen IS (1992). Rapid generation of sequence variation during primary HIV-1 infection [published erratum appears in AIDS 1992 Jun;6(6):following 606]. Aids 6: 453–460.
   Google Scholar
• Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz M, Ho DD (1997). Decay charac-teristics of HIV-1-infected compartments during com-bination therapy [see comments]. Nature 387: 188–191.
   Google Scholar
• Perrella O, Carrieri PB, Guarnaccia D, Soscia M (1992). Cerebrospinal fluid cytokines in AIDS dementia com-plex. J Neurol 239: 387–388.
   Google Scholar
• Sandhu GS, Eckloff BW, Kline BC (1991). Chemilumines-cent substrates increase sensitivity of antigen detection in Western blots. Biotechniques 11: 14–16.
   PubMedGoogle Scholar
• Sokal RR, Rohlf FJ (1995). Biometry (3rd ed). New York: W. H. Freeman.
   Google Scholar
• Tesmer VM, Rajadhyaksha A, Babin J, Bina M (1993). NF-1L6-mediated transcriptional activation of the long ter-minal repeat of the human immunodeficiency virus type 1. Proc Nail Acad Sci USA 90: 7298–7302.
   Google Scholar